Urogynecology Service, Assuta Medical Centers, Tel Aviv, Israel.

The purpose of this study was to evaluate the efficacy and safety of a novel disposable intravaginal device for treatment of stress urinary incontinence (SUI) in women.

Sixty women with severe SUI were recruited from 2 sites in Israel to wear preweighed pads during a 7-day control period followed by a 28-day device usage period in which the device and preweighed pads were worn daily for 8 hours. The primary endpoint was the percentage of women who achieved a >/= 70% reduction in pad weight gain (PWG) from the control period to the last 14 days of device usage.

Sixty women who enrolled into the study and used the device for any period of time were included in the intent to treat (ITT) population. Eighty-five percent of them achieved a >/= 70% reduction in PWG (P = .01). Improvements in overall quality of life, subjective perception of incontinence, and satisfaction with the device were observed.

The intravaginal device is easy to use, well-tolerated, and effective in reducing SUI.

Written by
Ziv E, Stanton SL, Abarbanel J.

Reference
Am J Obstet Gynecol. 2008 Mar 28. Epub ahead of print.
doi:10.1016/j.ajog.2008.01.061

PubMed Abstract
PMID:18377862

UroToday.com Stress Urinary Incontinence Section

Please log-in or register in order to submit comments.

Powered by AkoComment!